One Biosciences

1Cell.Ai

The company develops single-cell multi-omic analysis platforms for oncology researchers and drug developers to monitor therapies, discover biomarkers, and study tumour heterogeneity.

Turing Biosystems

Turing Biosystems develops an interpretable artificial intelligence platform and graph database to help pharmaceutical companies and clinicians optimise therapies by analysing multi-omics data.

QuirieGen

This company develops single-cell multi-omic technologies and AI models for drug discovery and development within the pharmaceutical sector.

Micrographia Bio

This company develops AI-driven microscopy and spatial proteomics platforms to help drug developers and researchers visualise molecular interactions and identify therapeutic targets.

Lightcast Bio

This company develops a microfluidic platform for single-cell functional analysis for pharmaceutical companies and academic research institutions.

Deepcell

Deepcell develops an artificial intelligence-powered imaging and sorting platform for single-cell morphology analysis, serving life sciences researchers, diagnostic labs, and pharmaceutical companies.

Known Medicine

This company develops a platform using 3D cell culture and artificial intelligence to predict drug responses for oncologists and biopharmaceutical developers.

Persona-Dx

The company develops artificial intelligence biomarker tests for tissue and blood samples to help oncologists personalise cancer diagnosis and treatment for metastatic patients.